Ribasure 200mg Capsule (Ribavirin 200mg)

Ribasure 200mg Capsule is an antiviral medication that is used to treat Hepatitis C Virus in combination with other medicines. This antiviral mainly treats the chronic infection in the body. It contains Ribavirin salt that attacks the viral replication machinery in the host's body.

Ribavirin stops viral replication mainly by being converted inside infected cells into an active form that directly inhibits the viral RNA polymerase enzyme, preventing the virus from copying its genetic material correctly.

Ribavirin also increases mutations in viral RNA, causing the production of defective viruses, and modulates the immune response to enhance antiviral activity. As a result, it reduces viral load in the body, reduces viral inflammation, controls virus progression as well as ultimately eradicating virus traces in the body.

Hepatitis C

Ribasure 200mg Capsule(Ribavirin 200mg) is a strong antiviral medicine that may show certain adverse while manageable impact on the body during the treatment. As these effects resolve on their own without any special medical attention. However, if you ever experience serious or unusual side effects contact your healthcare professional immediately.
Some common side effects of Ribasure 200mg include:
● Increased triglyceride level in blood
● Suicidal ideation
● Bacterial pneumonia
● Pneumothorax
● Swelling of lymph nodes
● Aggression
● Pharyngitis
● Decreased level of thyroid hormones
● Low blood platelets
● Headache
● Decreased appetite

The dosage is often weight-based, typically ranging from 800 to 1200 mg per day in divided doses. Ribasure 200mg Capsule is an orally administered medicine.

It is supposed to be swollen with water as it is. Avoid breaking, biting and chewing of capsule as it may affect the medicine efficacy. The dosage depends on the infection stage and pateints'overall health. Consult your doctor for your exact dosage and its timing.

● Pischke, S., Hardtke, S., Bode, U., Birkner, S., Chatzikyrkou, C., Kauffmann, W., ... & Wedemeyer, H. (2013). Ribavirin treatment of acute and chronic hepatitis E: a single‐centre experience. Liver International, 33(5), 722-726.
● Eggleston, M. (1987). Clinical review of ribavirin. Infection Control & Hospital Epidemiology, 8(5), 215-218.
● Dusheiko, G., Nelson, D., & Reddy, K. R. (2008). Ribavirin considerations in treatment optimization. Antiviral therapy, 13(1_suppl), 23-30.
● Narayana, K., D’Souza, U. J., & Rao, K. S. (2002). Ribavirin-induced sperm shape abnormalities in Wistar rat. Mutation Research/Genetic Toxicology and Environmental Mutagenesis, 513(1-2), 193-196.
● Reddy, K. R., Nelson, D. R., & Zeuzem, S. (2009). Ribavirin: current role in the optimal clinical management of chronic hepatitis C. Journal of hepatology, 50(2), 402-411.